1 Department of Infectious Diseases, Rigshospitalet-Copenhagen University Hospital, Copenhagen, Denmark. 2 Critical Care Medicine Department, National Institutes of Health Clinical Center, Bethesda, MD. 3 Centre for Medical Parasitology, Department of Clinical Microbiology, Rigshospitalet-Copenhagen University Hospital, and Department of International Health, Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark. 4 Department of Nephrology, Rigshospitalet-Copenhagen University Hospital, Copenhagen, Denmark. 5 Department of Surgical Gastroenterology, Rigshospitalet-Copenhagen University Hospital, Copenhagen, Denmark. 6 Department of Laboratory Medicine, National Institutes of Health Clinical Center, Bethesda, MD. 7 Address correspondence to Jannik Helweg-Larsen, M.D., D.M.Sci., Department of Infectious Diseases, Rigshospitalet-Copenhagen University Hospital, Blegdamsvej 9, 2100 Copenhagen, Denmark.
Transplantation. 2013 Nov 15;96(9):834-42. doi: 10.1097/TP.0b013e3182a1618c.
An outbreak of 29 cases of Pneumocystis jirovecii pneumonia (PCP) occurred among renal and liver transplant recipients (RTR and LTR) in the largest Danish transplantation centre between 2007 and 2010, when routine PCP prophylaxis was not used.
P. jirovecii isolates from 22 transplant cases, 2 colonized RTRs, and 19 Pneumocystis control samples were genotyped by restriction fragment length polymorphism and multilocus sequence typing analysis. Contact tracing was used to investigate transmission. Potential risk factors were compared between PCP cases and matched non-PCP transplant patients.
Three unique Pneumocystis genotypes were shared among 19 of the RTRs, LTRs, and a colonized RTR in three distinct clusters, two of which overlapped temporally. In contrast, Pneumocystis control samples harbored a wide range of genotypes. Evidence of possible nosocomial transmission was observed. Among several potential risk factors, only cytomegalovirus viremia was consistently associated with PCP (P=0.03; P=0.009). Mycophenolate mofetil was associated with PCP risk only in the RTR population (P=0.04).
We identified three large groups infected with unique strains of Pneumocystis and provide evidence of an outbreak profile and nosocomial transmission. LTRs may be infected in PCP outbreaks simultaneously with RTRs and by the same strains, most likely by interhuman transmission. Patients are at risk several years after transplantation, but the risk is highest during the first 6 months after transplantation. Because patients at risk cannot be identified clinically and outbreaks cannot be predicted, 6 months of PCP chemoprophylaxis should be considered for all RTRs and LTRs.
2007 年至 2010 年间,在丹麦最大的移植中心,29 例卡氏肺孢子菌肺炎(PCP)发生在肾和肝移植受者(RTR 和 LTR)中,当时未常规使用 PCP 预防。
通过限制性片段长度多态性和多位点序列分型分析,对 22 例移植病例、2 例定植 RTR 和 19 例卡氏肺孢子菌对照样本中的 P. jirovecii 分离株进行基因分型。进行接触追踪以调查传播情况。将潜在的危险因素与 PCP 病例和匹配的非 PCP 移植患者进行比较。
19 例 RTR、LTR 和 1 例定植 RTR 中存在三种独特的肺孢子菌基因型,分为三个不同的簇,其中两个簇在时间上重叠。相比之下,卡氏肺孢子菌对照样本携带广泛的基因型。观察到可能的医院内传播的证据。在几个潜在的危险因素中,只有巨细胞病毒血症与 PCP 始终相关(P=0.03;P=0.009)。吗替麦考酚酯仅在 RTR 人群中与 PCP 风险相关(P=0.04)。
我们确定了三组感染独特肺孢子菌菌株的大型感染群体,并提供了暴发情况和医院内传播的证据。LTR 可能与 RTR 同时且由同一菌株感染 PCP 暴发,最有可能通过人际传播。移植后数年患者存在风险,但在移植后 6 个月内风险最高。由于无法从临床角度识别处于风险中的患者,也无法预测暴发,因此所有 RTR 和 LTR 都应考虑接受 6 个月的 PCP 化学预防。